Minnesota Epilepsy Group PA — Saint Paul, Minnesota

Minnesota Epilepsy Group PA is a clinical research site located in Saint Paul, Minnesota, United States 55102.

Crixeo Health Trust Score: 52/100 (POOR). This profile has not yet been claimed by the site owner.

Minnesota Epilepsy Group PA has participated in 3 clinical trials.

Therapeutic areas: Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS), Lennox Gastaut Syndrome (LGS).

Sponsors: Eisai Inc., Takeda.

Sponsor Feasibility Report

Trust Score: 52/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Epilepsy Group PA?

Minnesota Epilepsy Group PA has a Crixeo Trust Score of 52/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Epilepsy Group PA conducted?

Minnesota Epilepsy Group PA has 3 clinical trials on record. Their work covers Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS), Lennox Gastaut Syndrome (LGS).

Is Minnesota Epilepsy Group PA accredited by Crixeo Health?

Minnesota Epilepsy Group PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Epilepsy Group PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.